Nascent Biotech (NBIO) News Today → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free NBIO Stock Alerts $0.10 0.00 (0.00%) (As of 05/20/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative April 16, 2024 | msn.comNascent Biotech prepares for pivotal Phase II research with fresh manufacturing runApril 16, 2024 | finanznachrichten.deNascent Biotech Inc.: Nascent Prepares for Pivotal Phase II Research with Fresh Manufacturing RunMarch 19, 2024 | finanznachrichten.deNascent Biotech Inc.: Nascent Collaborates With Hypospray Pharma on Proprietary Transdermal Delivery SystemMarch 2, 2024 | morningstar.comNascent Biotech Inc NBIOFebruary 6, 2024 | finanznachrichten.deNascent Biotech Inc.: Nascent Biotech and Manhattan BioSolutions Collaborate to Explore Pritumumab Antibody-Drug ConjugatesFebruary 6, 2024 | finance.yahoo.comNascent Biotech and Manhattan BioSolutions Collaborate to Explore Pritumumab Antibody-Drug ConjugatesJanuary 10, 2024 | finanznachrichten.deNascent Biotech Inc.: Nascent Biotech Receives an Analyst Opinion Suggesting that of the Company is Significantly Under ValuedJanuary 9, 2024 | finance.yahoo.comNascent Biotech Receives an Analyst Opinion Suggesting that of the Company is Significantly Under ValuedDecember 19, 2023 | finance.yahoo.comNascent Biotech Completes Payment of Variable Convertible Note in Full to Eliminate Dilution RiskNovember 29, 2023 | finance.yahoo.comNascent Biotech Granted Japanese Patent for Crossing Blood-Brain BarrierNovember 15, 2023 | usnews.comIsana Nascent AcademyOctober 26, 2023 | bizjournals.comChicago to showcase its biotech sector at capital summit next weekSeptember 2, 2023 | washingtonpost.comA tropical storm could threaten Florida next week. Here’s what we know.August 22, 2023 | finance.yahoo.comNascent Biotech to Begin Phase II Clinical Trials for Brain CancerJune 7, 2023 | finanznachrichten.deNascent Biotech Inc.: Nascent Biotech Phase I Clinical Data Presented at the American Society of Clinical Oncology Annual MeetingMay 26, 2023 | finanznachrichten.deNascent Biotech Inc.: Nascent Biotech Regains Worldwide Rights for PritumumabMay 26, 2023 | finance.yahoo.comNascent Biotech Regains Worldwide Rights for PritumumabMay 9, 2023 | finanznachrichten.deNascent Biotech Inc.: Nascent Biotech to Present Phase I Clinical Data at American Society of Clinical Oncology Annual MeetingMay 9, 2023 | finance.yahoo.comNascent Biotech to Present Phase I Clinical Data at American Society of Clinical Oncology Annual MeetingApril 18, 2023 | finanznachrichten.deNascent Biotech Inc.: Nascent Submits Phase 2 Clinical Research Protocol to FDA for Review and ApprovalApril 18, 2023 | finance.yahoo.comNascent Submits Phase 2 Clinical Research Protocol to FDA for Review and ApprovalFebruary 28, 2023 | finanznachrichten.deNascent Biotech Inc.: Nascent Announces the Completion of Its Phase1 Clinical TrialsFebruary 28, 2023 | finance.yahoo.comNascent Announces the Completion of Its Phase1 Clinical TrialsFebruary 14, 2023 | seekingalpha.comNBIO Nascent Biotech, Inc.January 25, 2023 | finanznachrichten.deNascent Biotech Inc.: Nascent Completes Dosing Requirement in Final Cohort of Phase I Clinical TrialJanuary 25, 2023 | finance.yahoo.comNascent Completes Dosing Requirement in Final Cohort of Phase I Clinical TrialJanuary 10, 2023 | finanznachrichten.deNascent Biotech Inc.: Nascent Enrolls Final Patient Cohort in Phase I Brain Cancer TrialJanuary 10, 2023 | finance.yahoo.comNascent Enrolls Final Patient Cohort in Phase I Brain Cancer TrialDecember 20, 2022 | finanznachrichten.deNascent Biotech Inc.: Nascent Biotech Announces Appointment of Dr. Ivan Babic to Scientific Advisory BoardDecember 20, 2022 | finance.yahoo.comNascent Biotech Announces Appointment of Dr. Ivan Babic to Scientific Advisory BoardNovember 2, 2022 | finanznachrichten.deNascent Biotech Inc.: Nascent Biotech Receives Notice of the Issuance of US Patent No.11,494,394November 1, 2022 | finance.yahoo.comNascent Biotech Receives Notice of the Issuance of US Patent No.11,494,394October 6, 2022 | seekingalpha.comNascent Biotech shares fall ~16%, on track for seventh session of losses in eightOctober 4, 2022 | finance.yahoo.comNascent Begins Enrollment of Final Patient Cohort to Complete Phase One Clinical ResearchSeptember 15, 2022 | finanznachrichten.deNascent Biotech Inc.: Nascent Biotech Completes Fourth Cohort in Phase 1 Human Trial for Primary and Metastatic Brain CancerSeptember 13, 2022 | finance.yahoo.comNascent Biotech Completes Fourth Cohort in Phase 1 Human Trial for Primary and Metastatic Brain CancerAugust 28, 2022 | apnews.comNascent Biotech - Changing the Biotechnology IndustryAugust 27, 2022 | finance.yahoo.comNascent Biotech, Inc. (NBIO)August 16, 2022 | nz.finance.yahoo.comChina Dongsheng International Change of Officers and DirectorsJuly 19, 2022 | finanznachrichten.deNascent Biotech Inc.: Nascent Biotech Receives Notice of Allowance from USPTO for Issuance of Additional PatentJuly 19, 2022 | finance.yahoo.comNascent Biotech Receives Notice of Allowance from USPTO for Issuance of Additional PatentJune 7, 2022 | finanznachrichten.deNascent Biotech Inc.: Nascent Biotech Completes Third Cohort in Phase 1 Human Trial for Primary and Metastatic Brain CancerJune 7, 2022 | finance.yahoo.comNascent Biotech Completes Third Cohort in Phase 1 Human Trial for Primary and Metastatic Brain CancerMay 6, 2022 | finanznachrichten.deNascent Biotech Inc.: Nascent Biotech's CEO Sean Carrick Featured in In-Depth Interview with Proactive InvestorsMay 4, 2022 | proactiveinvestors.comNascent Biotech approaching final cohort for its Phase I clinical study to treat brain cancerMay 4, 2022 | apnews.comNascent Biotech’s CEO Sean Carrick Featured in In-Depth Interview with Proactive InvestorsMay 4, 2022 | finance.yahoo.comNascent Biotech's CEO Sean Carrick Featured in In-Depth Interview with Proactive InvestorsApril 12, 2022 | finance.yahoo.comNascent Biotech and BioTools Partner in the Fight Against Cancer Using ROA to Define the Higher Order Structure of PTB, a Unique Monoclonal AntibodyMarch 8, 2022 | finance.yahoo.comThe Laurel Amtower Cancer Institute and Neuro-Oncology Center at Sharp HealthCare to Join Innovative Antibody Brain Cancer Drug TrialFebruary 23, 2022 | finanznachrichten.deNascent Biotech Inc.: Nascent Biotech Receives $750k Milestone Payment from BioRay Pharmaceutical Get Nascent Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for NBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Shocking $16T Elon Musk Crypto Leak (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. NBIO Media Mentions By Week NBIO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NBIO News Sentiment▼0.000.42▲Average Medical News Sentiment NBIO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NBIO Articles This Week▼00▲NBIO Articles Average Week Get Nascent Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for NBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AGNPF News Today AKBLF News Today DRTSW News Today ARNI News Today ARTLW News Today ASCLF News Today AWKNF News Today AXIM News Today BRRGF News Today BCTXW News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:NBIO) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsNext President (Not Trump. Not Biden.)The Freeport SocietyThe #1 Crypto for AIWeiss Ratings**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nascent Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.